Prevalence of hepatitis C rates in Ohio may indicate highest areas of opioid misuse


In an effort to further measure the opioid epidemic's impact in Ohio, the Ohio Alliance for Innovation in Population Health (The Alliance) studied hepatitis C rates within the state and discovered consistently high rates in the southern Appalachia region over a five-year period.

According to Orman Hall, a research team member on the study and executive in residence at Ohio University's College of Health Sciences and Professions (CHSP), these findings support the notion that Appalachian Ohio has been the hardest hit area of the state's opioid epidemic. Dr. Rifat Haider, assistant professor in CHSP's Department of Social and Public Health, concurred.

Tags for this resource